Advanthera

The development of advanced therapies is a complex process that goes far beyond the initial scientific discovery. Transforming an idea into a medicinal product capable of reaching patients requires planning, coordination and a deep understanding of both r

Scientific innovation alone is rarely enough to bring an advanced therapy to patients. From early research stages to future clinical application, advanced therapy medicinal products (ATMPs) require coordination between multiple disciplines, infrastructure

More and more companies are developing software as a medical device that incorporates Artificial Intelligence (AI) models.The applicable legal framework in these cases is critical, as it definitively influences its development, market introduction, implem

Advanced therapies often begin with a scientific question. In some cases, that question evolves over years of research, collaboration and clinical development into a therapeutic strategy capable of reaching patients. One example developed in Spain is Cely

Preclinical research is one of the most critical (and often underestimated) stages of ATMP development. Only a small percentage of therapies that show promising results in the laboratory ever reach patients. In advanced therapy medicinal products (ATMPs),

Regulatory strategy is one of the most complex and important aspects of advanced therapy development. As advanced therapies continue to evolve, developers face a regulatory landscape that is both highly demanding and constantly adapting to scientific inno